Uniphos Enter.

Why is Uniphos Enterprises Ltd falling/rising?

As of 03-Sep, Uniphos Enterprises Ltd's stock price is declining, currently at 93.04, with a year-to-date drop of -36.45% compared to the Sensex's -10.64%. The stock is underperforming, trading below its moving averages, and experiencing reduced investor interest, despite a high dividend yield of 3.74%.

As of 03-Sep, Uniphos Enterprises Ltd's stock price is falling, currently at 93.04, reflecting a change of -0.46 (-0.49%). The stock has been on a downward trend, having lost value for the last three consecutive days, resulting in a total decline of -3.08% during this period. Additionally, the stock's performance over various time frames shows significant underperformance compared to the benchmark Sensex, with a year-to-date decline of -36.45% versus the Sensex's -10.64%. <BR><BR>The stock is also trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Furthermore, there has been a notable decrease in investor participation, with delivery volume dropping by -75.39% compared to the 5-day average, suggesting reduced interest from investors. Despite a high dividend yield of 3.74%, these negative factors contribute to the stock's current decline.

Which are the latest news on Uniphos Enter.?

Who are in the management team of Uniphos Enter.?

The management team of Uniphos Enter includes R D Shroff (Managing Director), S R Shroff (Vice Chairperson), J R Shroff (Non-Executive Director), A C Ashar (Chairman), Pradeep Goyal and Swati S Mayekar (Non-Executive Independent Directors), and K M Thacker (Company Secretary & Compliance Officer).

The management team of Uniphos Enter includes the following individuals:<BR><BR>1. R D Shroff - Managing Director<BR>2. S R Shroff - Vice Chairperson<BR>3. J R Shroff - Non-Executive & Non-Independent Director<BR>4. A C Ashar - Chairman (Non-Executive)<BR>5. Pradeep Goyal - Non-Executive & Independent Director<BR>6. Swati S Mayekar - Non-Executive & Independent Director<BR>7. K M Thacker - Company Secretary & Compliance Officer<BR><BR>If you have any more questions about the company or its management, feel free to ask!

What does Uniphos Enter. do?

Uniphos Enterprises Ltd is a micro-cap company that manufactures specialty chemicals, including phosphorus compounds and pesticides. As of June 2026, it reported a net profit of -1 Cr and has a market cap of INR 692 Cr.

Overview:<BR>Uniphos Enterprises Ltd is a micro-cap company in the miscellaneous industry, primarily engaged in the manufacture of specialty chemicals including phosphorus compounds, pesticides, dyes, and plasticisers.<BR><BR>History:<BR>Incorporated in 1969 as United Phosphorus Limited, the company changed its name to Uniphos Enterprises Limited in October 2003. The latest quarterly results reported a net profit of -1 Cr for June 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: -1 Cr (Quarterly Results - Jun 2026)<BR>Market-cap value: INR 692 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 33.00<BR>Industry P/E: 21<BR>Dividend Yield: 4.26%<BR>Debt-Equity: -0.01<BR>Return on Equity: 0.83%<BR>Price to Book: 0.27<BR><BR>Contact Details:<BR>Address: 11 GIDC, Valsad Dist VAPI Gujarat : 396195<BR>Phone: 91-0260-2400717<BR>Email: thackerkm@uniphos.com<BR>Website: http://www.uelonline.com

Who are the peers of the Uniphos Enter.?

Uniphos Enterprises' peers include R M Drip & Sprin, Kokuyo Camlin, Everest Inds., Linc, S Chand & Company, Repro India, Namo eWaste, Vasa Denticity, and Vision Infra. Namo eWaste shows the best management and growth metrics, while Uniphos has below-average growth and capital structure, with a 1-year return of -36.82%.

Peers: The peers of Uniphos Enter. are R M Drip & Sprin, Kokuyo Camlin, Everest Inds., Linc, S Chand & Compan, Repro India, Namo eWaste, Vasa Denticity, Vision Infra.<BR><BR>Quality Snapshot: Excellent management risk is observed at Namo eWaste, while Average management risk is found at R M Drip & Sprin, Kokuyo Camlin, Uniphos Enter., Everest Inds., Linc, S Chand & Compan, Repro India, and Vision Infra, and the rest. Growth is Excellent at Namo eWaste, Good at Linc and S Chand & Compan, while Average growth is noted at R M Drip & Sprin, Kokuyo Camlin, and Vision Infra, and Below Average growth is seen at Uniphos Enter., Everest Inds., Repro India, Vasa Denticity, and the rest. Capital Structure is Excellent at Namo eWaste and Linc, Good at Kokuyo Camlin and S Chand & Compan, while Below Average capital structure is found at Uniphos Enter., Everest Inds., Repro India, Vasa Denticity, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Namo eWaste at 0.00%, while the lowest is R M Drip & Sprin at -50.26%. Uniphos Enter.'s 1-year return of -36.82% is better than R M Drip & Sprin but worse than Namo eWaste. Additionally, the six-month return is negative for R M Drip & Sprin, Kokuyo Camlin, Uniphos Enter., Everest Inds., Linc, S Chand & Compan, Repro India, and Vasa Denticity.

How big is Uniphos Enter.?

As of 31st August, Uniphos Enterprises Ltd has a market capitalization of 692.00 Cr, with recent net sales of 26.14 Cr and a net profit of 20.26 Cr. The company reported shareholder's funds of 2,446.77 Cr and total assets of 2,618.84 Cr for the annual period ending March 2026.

As of 31st August, Uniphos Enterprises Ltd has a market capitalization of 692.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Uniphos Enterprises Ltd reported Net Sales of 26.14 Cr and a Net Profit of 20.26 Cr.<BR><BR>For the latest annual period ending in March 2026, the company had Shareholder's Funds amounting to 2,446.77 Cr and Total Assets of 2,618.84 Cr.

Should I buy, sell or hold Uniphos Enterprises Ltd?

When is the next results date for Uniphos Enterprises Ltd?

The next results date for Uniphos Enterprises Ltd is 12 August 2026.

The next results date for Uniphos Enterprises Ltd is scheduled for 12 August 2026.

Are Uniphos Enterprises Ltd latest results good or bad?

Uniphos Enterprises Ltd's latest Q4 FY26 results are unfavorable, showing a net loss of ₹0.70 crores and a significant 64.14% decline in revenue year-over-year. Despite a slight improvement in losses compared to last year, the company's negative margins and low return on equity indicate ongoing operational challenges.

Uniphos Enterprises Ltd's latest results for Q4 FY26 indicate a challenging financial situation. The company reported a net loss of ₹0.70 crores, which, while an improvement from a loss of ₹1.58 crores in the same quarter last year, still reflects ongoing operational weaknesses. Revenue for the quarter was ₹26.14 crores, marking a significant decline of 64.14% year-over-year from ₹72.90 crores in Q4 FY25.<BR><BR>The company's profitability metrics remain concerning, with a negative PAT margin of -2.68%, which is worse than the previous year's -2.17%. Additionally, the return on equity (ROE) is extremely low at 0.73%, indicating poor capital efficiency. The overall financial performance has been erratic, with extreme revenue volatility and persistent losses raising serious questions about the company's business model and viability.<BR><BR>In summary, while there is a slight narrowing of losses compared to the previous year, the overall financial results are poor, characterized by significant revenue decline, negative margins, and weak operational performance. This paints a picture of a company facing substantial challenges, making the latest results largely unfavorable.

Is Uniphos Enter. technically bullish or bearish?

As of December 4, 2025, the technical trend has shifted to a moderately strong bearish stance, driven by bearish MACD, Bollinger Bands, and moving averages, despite a mildly bullish OBV signal on the monthly chart.

As of 4 December 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this include a bearish MACD on the weekly timeframe, bearish signals from Bollinger Bands on both weekly and monthly charts, and bearish moving averages on the daily chart. The KST is also bearish across both timeframes. Although the OBV shows a mildly bullish signal on the monthly, it does not outweigh the overall bearish indicators.

How has been the historical performance of Uniphos Enter.?

Uniphos Enter. has shown significant sales growth, with net sales rising from 1.47 Cr in March 2023 to 111.51 Cr in March 2025. However, it faces profitability challenges, as operating profit declined and cash flow from operations remained negative.

Answer:<BR>The historical performance of Uniphos Enter. shows significant fluctuations in its financial metrics over the years, particularly from March 2019 to March 2025.<BR><BR>Breakdown:<BR>Uniphos Enter. experienced a dramatic increase in net sales from 1.47 Cr in March 2023 to 111.51 Cr in March 2025, reflecting a substantial growth trajectory. However, the total expenditure also rose sharply, leading to an operating profit (PBDIT) of 2.29 Cr in March 2025, down from 39.78 Cr in March 2024. This decline in operating profit is accompanied by a negative operating profit margin of -3.43% in March 2025, indicating challenges in managing costs relative to revenue. Profit before tax decreased to 0.23 Cr in March 2025 from 38.94 Cr in March 2024, while profit after tax also fell to 0.28 Cr from 38.61 Cr in the previous year. The company's reserves increased to 2,727.74 Cr in March 2025, up from 2,061.54 Cr in March 2024, yet the book value per share adjusted to 373.37 in March 2025 from 277.58 in March 2024. Cash flow from operating activities remained negative at -2.00 Cr in March 2025, although cash flow from investing activities improved to 52.00 Cr. Overall, while Uniphos Enter. has shown remarkable sales growth, it faces challenges in profitability and cash flow management.

Who are the top shareholders of the Uniphos Enter.?

The top shareholders of Uniphos Enterprises include Nerka Chemicals Pvt Ltd with 73.29%, 15 Foreign Institutional Investors holding 15.72%, and Ares Diversified as the largest public shareholder at 4.56%. Individual investors own 8.91%, with no pledged promoter holdings reported.

The top shareholders of Uniphos Enterprises include the promoters, with Nerka Chemicals Pvt Ltd holding the largest share at 73.29%. Additionally, 15 Foreign Institutional Investors (FIIs) collectively hold 15.72% of the shares. The highest public shareholder is Ares Diversified, which owns 4.56%. Individual investors account for 8.91% of the shareholding. There are no pledged promoter holdings reported.

Has Uniphos Enter. declared dividend?

Uniphos Enterprises Ltd has declared a 285% dividend, amounting to ₹5.7 per share, with an ex-date of September 6, 2024. The company has shown strong total returns across various periods, particularly a 225.14% total return over the past five years.

Uniphos Enterprises Ltd has declared a 285% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 285%<BR>- Amount per share: 5.7<BR>- Ex-date: 06 Sep 2024<BR><BR>Dividend Yield: 3.56%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was 0.95%, with no dividend return, resulting in a total return of 0.95%.<BR><BR>For the 1-year period, the price return was 0.25%, with a dividend return of 3.45%, leading to a total return of 3.7%.<BR><BR>Over the 2-year period, the price return was 4.95%, the dividend return was 7.66%, culminating in a total return of 12.61%.<BR><BR>In the 3-year period, the price return was 28.23%, with a dividend return of 14.76%, resulting in a total return of 42.99%.<BR><BR>During the 4-year period, the price return was 32.78%, the dividend return was 16.29%, leading to a total return of 49.07%.<BR><BR>Finally, in the 5-year period, the price return was 189.62%, with a dividend return of 35.52%, resulting in a total return of 225.14%.<BR><BR>Overall, Uniphos Enterprises Ltd has shown a strong commitment to returning value to shareholders through its significant dividend declaration and has demonstrated positive total returns across all periods, particularly over the longer term.